SG Americas Securities LLC bought a new position in AnaptysBio, Inc. (NASDAQ:ANAB – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 5,875 shares of the biotechnology company’s stock, valued at approximately $126,000. Other large investors also recently modified their […]